Company Titan Pharmaceuticals, Inc. Nasdaq
Equities
US8883143096
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -66.97% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -66.97% |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15/22/15 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12/23/12 |
Brynner Chiam
BRD | Director/Board Member | - | 12/23/12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 914,234 | 498,544 ( 54.53 %) | 0 | 54.53 % |
Stock B | 0 | 950,000 | 0 | 0 |
Company contact information
Titan Pharmaceuticals, Inc.
400 Oyster Point Boulevard Suite 505
94080-1958, South San Francisco
+650 244 4990
http://www.titanpharm.comSector
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |